Early neovascular bridging after photodynamic therapy of myopic choroidal neovascularization

Paolo Lanzetta, Maurizio Battaglia Parodi, Massimo Ambesi-Impiombato, Giuseppe Ravalico, Francesco Bandello

Research output: Contribution to journalArticlepeer-review


Background: Photodynamic therapy is a relatively new modality for the treatment of subfoveal choroidal neovascularization (CNV). An unusual response to verteporfin therapy of myopic CNVs is reported. Methods: Out of 187 CNVs secondary to pathologic myopia treated with photodynamic therapy, three eyes manifested two separate foci of CNV before treatment. The three eyes were treated with verteporfin therapy according to the standard protocol, using a single spot of light that covered both neovascular fronds. Results: All the three eyes showed neo vascular bridging of the two separate neovascular complexes 1 month after treatment. Conclusions: Eyes with multiple foci of myopic CNV may show unexpected outcomes after verteporfin therapy. Several factors, such as changes of the retinal pigment epithelium and choroidal vasculature involved in the treatment and enhanced expression of vascular endothelial growth factor, may play a role.

Original languageEnglish
Pages (from-to)840-844
Number of pages5
JournalGraefe's Archive for Clinical and Experimental Ophthalmology
Issue number10
Publication statusPublished - Oct 2004

ASJC Scopus subject areas

  • Ophthalmology


Dive into the research topics of 'Early neovascular bridging after photodynamic therapy of myopic choroidal neovascularization'. Together they form a unique fingerprint.

Cite this